Close Menu

NEW YORK — Cytovale announced today it has received a total of $15 million in financing to advance its technology for the early detection of sepsis in the emergency department.

The funding includes a $7.4 million extension of a Series B equity financing and a partnership with the US Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) that is valued at up to $7.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.